STREAMING NOW: Watch Now

Active ingredient in ecstasy may help veterans with PTSD, study finds

MDMA -- the active ingredient in the banned street drug ecstasy -- is safe and enhances the treatment of post-trauma...

Posted: May 3, 2018 1:26 PM
Updated: May 3, 2018 1:26 PM

MDMA -- the active ingredient in the banned street drug ecstasy -- is safe and enhances the treatment of post-traumatic stress disorder when administered during psychotherapy, according to a new clinical trial.

More research is needed to fully assess the drug, caution the authors of the US Food and Drug Administration-approved experiment. The study included just 26 patients, all of them veterans, firefighters and police officers who developed PTSD as a result of trauma in the line of duty.

Effects of psychotherapy and sessions of MDMA-assisted psychotherapy were studied

One year later, 67% of all participants no longer qualified for a diagnosis of PTSD

MDMA -- or 3,4-methylenedioxymethamphetamine -- has been illegal in the United States since 1985.

"MDMA has some stimulant effects as well as psychoactive effects," said Dr. Michael C. Mithoefer, lead author of the study and a psychiatrist in the department of psychiatry and behavioral sciences at the Medical University of South Carolina.

The drug is sometimes described as an "empathogen" or "entactogen," he added, because it "rarely causes hallucinations or disorientation and tends to increase feelings of empathy and trust and increased awareness of inner experience."

"We obtained FDA approval for our first clinical trial in 2001," Mithoefer said. "We began our first phase two clinical trial here in Charleston in 2004 treating mostly crime-related PTSD such as childhood abuse or rape in individuals who had failed to respond to psychotherapy and medications."

Promising results from previous trials led to the new study, published Tuesday in the journal The Lancet Psychiatry, he said.

Search for new therapies

PTSD, a disorder that develops in some people who have experienced a shocking or dangerous event, affects about 8 million American in any given year.

Continuing symptoms, including flashbacks and frightening thoughts, may lead to substance abuse, unemployment, family disruption and even suicide. Existing treatments for PTSD include various forms of psychotherapy, such as exposure therapy and cognitive processing therapy, and/or prescription drugs, such as antidepressants.

Up to 72% of veterans who receive psychotherapy retain their PTSD diagnosis and frequently drop out of their treatment programs, according to a previous unrelated study.

The need for improved PTSD therapies is clear, Mithoefer and his co-authors say, adding that the "development of new treatments should address the common reasons for treatment avoidance, failure, and dropout."

The Multidisciplinary Association for Psychedelic Studies, a nonprofit research organization, funded Mithoefer's study of 22 veterans, three firefighters and one police officer, all with service-related PTSD lasting longer than six months.

"We only included people who had received prior treatment but still had clinically significant PTSD," Mithoefer said of the study, which followed the FDA's strict guidelines for a phase two trial.

All 26 participants received a course of treatment that consisted of about 13 hours of non-drug psychotherapy plus two eight-hour sessions of MDMA-assisted psychotherapy. Participants were randomly assigned to receive MDMA (orally) in one dose of either 30, 75 or 125 milligrams for each of the two MDMA-assisted psychotherapy sessions.

One month after the second MDMA session, 68% of patients in the two higher-dose groups no longer qualified for a diagnosis of PTSD, while the same was true of 29% of patients in the lowest-dose group. One year later, 67% of all participants no longer qualified for a diagnosis of PTSD, the study results indicate. Those participants who still met the criteria for PTSD experienced a reduction in symptoms, the researchers noted.

Experts disagree on findings

The most frequently reported immediate side effects of MDMA were anxiety, headache, fatigue and muscle tension. One week after treatment, some participants experienced anxiety, fatigue and insomnia. Four serious side effects were reported during the course of the study, though three of these events -- suicide ideation, major depression and appendicitis -- were not attributed to MDMA.

One participant experienced premature ventricular contractions -- extra beats in one chamber of the heart -- at the outset of the study and during the study. After an overnight stay in a hospital, the patient recovered fully, the researchers reported.

Dr. Neil Greenberg, a professor of defence mental health at King's College London, said the study may be "interesting" but does not "fundamentally change" the services offered for PTSD treatment.

Greenberg, who was not involved in the study, noted that 22 of the 26 participants had been recruited from the internet, "and one has to assume they were interested in taking a psychedelic drug." He also said that some of the participants received prior treatments that were either not evidence-based or known to be effective with PTSD; a sample "bias" such as this weakens the quality of any analysis.

Overall, he said, future research of the effects of MDMA on patients with PTSD might be watched with interest, but he does not recommend any stronger actions, "given the controversial nature of the medication, the risk of serious side effects and the small and biased sample" of participants.

But David Nutt, a professor of neuropsychopharmacology at Imperial College London, said the new study is "the biggest breakthrough in medicinal PTSD treatment for two decades" and "opens a potential new era in the treatment of PTSD."

According to Nutt, who was not involved in the study, the results suggest that "MDMA should be fast-tracked to clinical acceptance" since the evidence is now sufficient to warrant its wider use in treating PTSD.

In his own research, Nutt explored the neurological effects of MDMA in healthy participants. His work showed that MDMA "reduces fear responses, which probably explains how it works to aid psychotherapy in PTSD," he said.

Nutt will be conducting a study of MDMA in alcoholics who drink in an attempt to deal with prior trauma.

Not a 'daily drug'

MDMA was first synthesized in 1912 by a German pharmaceutical company that intended to use it as a blood clotting agent. In the 1970s, a small number of psychotherapists made use of it in couples' therapy, where it was shown to help traumatized clients address repressed emotional memories "without being overwhelmed by the negative affect that usually accompanies such memories," Nutt wrote in a report. In the 1980s, MDMA lost its legal status around the world under a United Nations agreement, having fallen into disrepute as a street drug.

However, some scientists remained convinced of its potential and persisted in their research. In the early 1990s, the FDA approved experiments in which MDMA was used as an adjunct to psychotherapy. Ongoing research in a similar vein resulted in the new study, among others, in addition to the FDA agreeing in 2017 to expedite its review of MDMA-assisted psychotherapy for PTSD.

Phase three clinical trials of MDMA-assisted psychotherapy for PTSD, involving 200 to 300 participants across 16 sites in the United States, Canada and Israel, will begin in the summer, according to Mithoefer. If these trials demonstrate sufficient efficacy and an acceptable safety profile, FDA approval of the treatment is expected by 2021.

"Unlike most other drug studies, MDMA is not being used as a daily drug," Mithoefer said. Using the drug as a catalyst to psychotherapy means it is used only a few times, at monthly intervals, which is appealing to psychiatrists, he noted. "Taking it only a few times decreases side effects compared to daily dosing," he said, and it "eliminates the possibility of abuse, since it is administered directly by the therapists."

"If it is approved by FDA for clinical use, it will likely be restricted to specialized clinics with properly trained therapists, not as a take-home medicine that people get from the pharmacy," Mithoefer said.

Click to Submit Photo

 

 

Huntsville
Broken Clouds
68° wxIcon
Hi: 69° Lo: 58°
Feels Like: 68°
Florence
Overcast
68° wxIcon
Hi: 67° Lo: 56°
Feels Like: 68°
Fayetteville
Overcast
68° wxIcon
Hi: 70° Lo: 57°
Feels Like: 68°
Decatur
Overcast
67° wxIcon
Hi: 67° Lo: 57°
Feels Like: 67°
Scottsboro
Overcast
72° wxIcon
Hi: 71° Lo: 60°
Feels Like: 72°
WAAY Radar
WAAY WAAY-TV Cam
WAAY Temperatures

Alabama Coronavirus Cases

Confirmed Cases: 155915

Reported Deaths: 2674
CountyConfirmedDeaths
Jefferson23129377
Mobile16849315
Tuscaloosa10296140
Montgomery10197197
Madison928096
Shelby733863
Baldwin663769
Lee653465
Calhoun456761
Marshall438150
Etowah426551
Houston414834
Morgan412035
DeKalb338829
Elmore320053
St. Clair292542
Limestone284230
Walker277292
Talladega265335
Cullman244024
Lauderdale226242
Jackson214915
Franklin205231
Autauga204831
Colbert200532
Russell19443
Blount192525
Chilton186932
Dallas186527
Coffee176311
Dale175151
Covington174029
Escambia172530
Chambers135044
Clarke134317
Pike133513
Tallapoosa131787
Marion107629
Barbour10319
Marengo100822
Butler100740
Winston92213
Geneva9007
Lawrence85032
Pickens84718
Bibb82814
Randolph82316
Hale76730
Washington74412
Clay74112
Cherokee73314
Lowndes70928
Henry7086
Bullock64817
Monroe64610
Crenshaw60630
Perry5896
Fayette57413
Wilcox56712
Conecuh56113
Cleburne5568
Macon53420
Lamar4905
Sumter47221
Choctaw39012
Greene34216
Coosa2033
Out of AL00
Unassigned00

Tennessee Coronavirus Cases

Confirmed Cases: 244087

Reported Deaths: 3100
CountyConfirmedDeaths
Shelby35753562
Davidson31206336
Knox1256189
Hamilton11618108
Rutherford11611112
Williamson697156
Sumner5948109
Wilson462956
Putnam440356
Montgomery411555
Out of TN389635
Madison374079
Sullivan365346
Bradley355823
Washington338850
Sevier332821
Blount330936
Maury321837
Unassigned29539
Robertson258941
Hamblen244548
Tipton232222
Dyer218930
Gibson213043
Hardeman186433
Coffee185323
Trousdale17687
Obion174121
Greene168451
Bedford168120
Fayette166723
Anderson166614
Dickson164819
McMinn161535
Loudon161211
Cumberland159525
Wayne15917
Lawrence158719
Jefferson153720
Carter152932
Weakley152325
Monroe144328
Warren142510
Lauderdale142317
Henderson140226
Hardin137919
Macon132425
Roane12857
Franklin127819
Haywood127227
Overton121316
Hawkins118825
White117514
Johnson11327
Carroll113025
Marshall11269
McNairy111227
Rhea109317
Cheatham104111
Cocke103514
Bledsoe10114
Campbell100011
Smith98413
Lake9833
Giles95135
Fentress90811
Lincoln8803
Crockett83320
Henry78110
Hickman77915
Marion7479
Chester72514
DeKalb72517
Decatur65511
Grainger6034
Grundy55311
Union5383
Claiborne5186
Polk50313
Jackson4525
Humphreys4404
Morgan4357
Benton4139
Houston40917
Cannon4082
Unicoi4043
Clay40113
Lewis3852
Scott3745
Sequatchie3422
Stewart32010
Meigs3076
Perry2912
Pickett2727
Moore2652
Van Buren2051
Hancock1173

Community Events